Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
disease | 0.400 | None | 0.667 | 4 | 0 | 1998 | 2011 | ||||||||
|
trace amine associated receptor 6 | 0.780 | 0.231 | 1.7E-02 |
|
disease | 0.100 | None | 0.727 | 4 | 0 | 2004 | 2019 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
disease | 0.600 | None | 0.951 | 4 | 0 | 2000 | 2019 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit beta2 | 0.619 | 0.500 | 0.85 |
|
disease | 0.400 | None | 0.955 | 4 | 0 | 2004 | 2019 | ||||||||
|
cytochrome P450 family 2 subfamily D member 6 | 0.437 | 0.885 | 1.1E-25 |
|
disease | 0.400 | None | 0.400 | 4 | 0 | 1994 | 2019 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.600 | None | 0.780 | 4 | 0 | 1995 | 2019 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.900 | limited | 0.865 | 4 | 0 | 2001 | 2019 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
disease | 0.700 | None | 0.964 | 4 | 0 | 1995 | 2019 | ||||||||
|
reticulon 4 receptor | 0.595 | 0.692 | 0.96 |
|
disease | 0.670 | None | 0.857 | 3 | 0 | 2004 | 2017 | ||||||||
|
solute carrier family 6 member 3 | 0.453 | 0.885 | 1.00 |
|
disease | 0.600 | None | 0.964 | 3 | 0 | 1993 | 2020 | ||||||||
|
chromogranin B | 0.599 | 0.654 | 2.4E-07 |
|
disease | 0.340 | None | 1.000 | 3 | 0 | 2002 | 2017 | ||||||||
|
neurotrophic receptor tyrosine kinase 2 | 0.479 | 0.808 | 1.00 |
|
disease | 0.380 | None | 0.500 | 3 | 0 | 2003 | 2016 | ||||||||
|
5-hydroxytryptamine receptor 2C | 0.555 | 0.692 | 3.7E-02 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 1995 | 2019 | ||||||||
|
nuclear receptor subfamily 4 group A member 2 | 0.529 | 0.846 | 1.00 |
|
disease | 0.600 | None | 0.800 | 3 | 0 | 1999 | 2020 | ||||||||
|
protein phosphatase 1 regulatory inhibitor subunit 1B | 0.617 | 0.500 | 0.24 |
|
disease | 0.600 | None | 1.000 | 3 | 0 | 2006 | 2019 | ||||||||
|
tryptophan hydroxylase 1 | 0.553 | 0.731 | 3.2E-07 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 2000 | 2017 | ||||||||
|
plexin A2 | 0.447 | 0.808 | 1.1E-06 |
|
disease | 0.370 | None | 1.000 | 3 | 0 | 2006 | 2018 | ||||||||
|
claudin 5 | 0.559 | 0.769 | 0.90 |
|
disease | 0.390 | None | 1.000 | 3 | 0 | 2004 | 2019 | ||||||||
|
phosphodiesterase 4B | 0.566 | 0.731 | 0.47 |
|
disease | 0.500 | None | 0.957 | 3 | 0 | 2005 | 2019 | ||||||||
|
synapsin II | 0.653 | 0.577 |
|
disease | 0.490 | None | 0.889 | 3 | 0 | 2000 | 2019 | |||||||||
|
solute carrier family 18 member A2 | 0.554 | 0.769 | 7.6E-02 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 1995 | 2018 | ||||||||
|
5-hydroxytryptamine receptor 1A | 0.522 | 0.846 | 0.20 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 1991 | 2019 | ||||||||
|
synapsin III | 0.686 | 0.462 | 1.9E-03 |
|
disease | 0.400 | None | 0.500 | 3 | 0 | 2000 | 2009 | ||||||||
|
phosphatidylinositol-5-phosphate 4-kinase type 2 alpha | 0.647 | 0.423 | 0.14 |
|
disease | 0.400 | None | 0.750 | 3 | 0 | 2005 | 2014 | ||||||||
|
myelin associated glycoprotein | 0.579 | 0.692 | 0.49 |
|
disease | 0.400 | None | 0.400 | 3 | 0 | 2004 | 2011 |